Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_329737875dcc81685bb34e2277ef2150 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38cdb3dd06828d96044e01298a12f709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e57978b7e75f3ca54b56772b4fc5984 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3662ce5995dada5ea3d9873552592af0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1499ef48a9e5fb0a742214128b4cc435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bb3a255e674723306cf4a1ee2647e8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7946ec4f3ab0ccdf6d369bf5079567ea |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2011-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f80c0364e8f9a1d8b92e6034c8ab375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_850786a5bdde756e3297a80d9a60f4eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd9d0ef330d5e4ed107263c8d18133c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2eae77e883c6286010f9bf479439c7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dacd7184a7b866705094393db75d7505 |
publicationDate |
2014-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014242081-A1 |
titleOfInvention |
Dosing regimens for treatment of cea-expressing cancers |
abstract |
The present disclosure provides compositions and methods for treating CEA-expressing cancers. Methods for dosing a patient with an antibody that binds to CEA and human CD3 are also provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018014001-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021269546-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111954-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884921-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10308688-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10239938-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10245321-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10183992-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9682143-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434291-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113194990-A |
priorityDate |
2011-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |